Suraksha Diagnostic Limited (BOM:544293)

Market Cap	14.82B +9.0%
Revenue (ttm)	2.94B +21.2%
Net Income	332.95M +7.6%
EPS	6.25 +5.9%
Shares Out	n/a
PE Ratio	44.50
Forward PE	38.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	630
Average Volume	2,493
Open	280.50
Previous Close	281.70
Day's Range	280.50 - 285.00
52-Week Range	224.10 - 353.65
Beta	n/a
RSI	64.26
Earnings Date	May 26, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al...

• Industry: Medical Laboratories
• Founded: 1992
• Employees: 1,300
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544293

Financial Performance

In fiscal year 2025, Suraksha Diagnostic's revenue was 2.52 billion, an increase of 15.26% compared to the previous year's 2.19 billion. Earnings were 318.24 million, an increase of 34.70%.